Focus: Median Technologies is an imaging phenomics biotech company headquartered in Shanghai, focused on oncology and cancer detection using advanced imaging analytics. Founded in 2024 and publicly traded, the company operates as a specialized imaging and clinical trial services provider.
Profile data last refreshed 16h ago · AI intelligence enriched 3w ago
Stable — net +2 jobs in 30d
3 added, 1 removed. Backfill posture.
High-potential early-stage opportunity for those comfortable with a newly public, Shanghai-based imaging biotech; proceed with caution on financial stability and headcount growth.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Median Technologies
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Median Technologies's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Median Technologies Secures One of the Largest iCRO Projects in Its History - 01net
Median Technologies Secures One of the Largest iCRO Projects in Its History 01net
Median Technologies Secures ?8.4 Million Global Phase III Oncology Imaging Project from European Pharmaceutical Company - marketscreener.com
Median Technologies Secures ?8.4 Million Global Phase III Oncology Imaging Project from European Pharmaceutical Company marketscreener.com
Median Technologies lands a major €8.4m contract - www.marketscreener.com
Median Technologies lands a major €8.4m contract www.marketscreener.com
Median Technologies Secures One of the Largest iCRO Projects in Its History - Business Wire
Median Technologies Secures One of the Largest iCRO Projects in Its History Business Wire
Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of July 31, 2026 - Yahoo Finance
Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of July 31, 2026 Yahoo Finance
25 Healthcare AI Use Cases with Examples - AIMultiple
25 Healthcare AI Use Cases with Examples AIMultiple
Showing 6 of 10 news items
Based on last 4 crawl cycles
Source: USCIS H-1B Employer Data Hub
Recent peer-reviewed publications with author affiliations at this company
Showing 5 of 10 publications
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo